Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
The association between RAB40AL and Martin-Probst syndrome has been reported in an initial case study where a p.Asp59Gly variant (c.176A>G) was identified in two unrelated affected males, with segregation noted in an X‑linked pedigree (PMID:24863632). However, subsequent multi‐patient analyses have raised serious concerns regarding the pathogenicity of this variant. These larger studies, which included screening of control populations (PMID:25044830, PMID:25370018, PMID:26300074), found a relatively high allele frequency of p.Asp59Gly in unaffected individuals, thereby challenging its causal role in the disorder.
In contrast, functional evidence demonstrates that the p.Asp59Gly variant disrupts RAB40AL function by destabilizing the protein and altering its subcellular localization, which is consistent with some features of the syndrome (PMID:22581972). Overall, while the functional data support a deleterious impact at the cellular level, the conflicting genetic data and the high prevalence of the variant in control cohorts render the gene‐disease association clinically disputed. Key take‑home: Cautious interpretation of RAB40AL p.Asp59Gly in clinical diagnostics is warranted, given its functional perturbation yet questionable disease specificity.
Gene–Disease AssociationDisputedAlthough an initial case report (PMID:24863632) identified the p.Asp59Gly variant with suggestive segregation, multiple independent studies (PMID:25044830, PMID:25370018, PMID:26300074) have shown a high prevalence of the variant in controls, undermining its pathogenic association. Genetic EvidenceLimitedThe genetic evidence is based on only two reported probands carrying the p.Asp59Gly variant, with conflicting segregation findings across studies. Functional EvidenceModerateFunctional assays demonstrated that the p.Asp59Gly variant impairs RAB40AL stability and cellular localization, aligning with aspects of the disease phenotype (PMID:22581972). |